Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids
Mathias Tiedemann Svendsen,1–3 Klaus Ejner Andersen,1–3 Flemming Andersen,1,3 Jakob Hansen,4 Anton Pottegård,5 Helle Johannessen6 1Department of Dermatology and Allergy Centre, Odense University Hospital, 2Centre for Innovative Medical Technology, Institute of Clinical...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c2070627e5e745959d5602a2042f0117 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c2070627e5e745959d5602a2042f0117 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c2070627e5e745959d5602a2042f01172021-12-02T09:23:25ZPsoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids2230-326Xhttps://doaj.org/article/c2070627e5e745959d5602a2042f01172016-08-01T00:00:00Zhttps://www.dovepress.com/psoriasis-patientsrsquo-experiences-concerning-medical-adherence-to-tr-peer-reviewed-article-PTThttps://doaj.org/toc/2230-326XMathias Tiedemann Svendsen,1–3 Klaus Ejner Andersen,1–3 Flemming Andersen,1,3 Jakob Hansen,4 Anton Pottegård,5 Helle Johannessen6 1Department of Dermatology and Allergy Centre, Odense University Hospital, 2Centre for Innovative Medical Technology, Institute of Clinical Research, University of Southern Denmark, Odense C, 3Dermatological Investigations Scandinavia, University of Southern Denmark, Odense C, 4Leo Pharma, Ballerup, 5Clinical Pharmacology, Department of Public Health, University of Southern Denmark, 6Research Unit of User Perspectives, Department of Public Health, University of Southern Denmark, Odense C, Denmark Abstract: Nonadherence to topical treatment of psoriasis is a common cause of treatment failure. This focus group study was conducted to obtain the patients’ own experiences and explanations regarding medical adherence. The participants consisted of eight primary adherent patients with moderate psoriasis treated with corticosteroid or corticosteroid–calcipotriol combinations, purposefully sampled by age and sex at a dermatology outpatient clinic. Secondary medical adherence was supported by accessibility of the prescribing physician, the prescriber taking time to listen, having a more manageable disease, using a nonstaining product, and establishing routines around treatment at home. Secondary medical adherence was affected negatively by changes in daily routines, if the treatment influenced the patient’s sexual life, having too little time in the consultation room, lack of confidence in the prescriber, diverging information from health care personnel, experiencing side effects, having fear of side effects, impractical formulations of topical products, and impatience regarding time before an effect of the treatment was observed. From this study, the recommendations for the prescribing doctor to improve medical adherence are, the doctor needs to take time to listen to the patient, prescribe a topical product that is easy to apply and less greasy, inform the patients about benefits from treatments, and explain the rationale behind the treatment plan. Keywords: psoriasis, adherence, corticosteroids, calcipotriol, focus groupsSvendsen MTAndersen KEAndersen FHansen JPottegård AJohannessen HDove Medical PressarticlePsoriasisadherencecorticosteroidscalcipotriolfocus groupsDermatologyRL1-803ENPsoriasis: Targets and Therapy, Vol Volume 6, Pp 113-119 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Psoriasis adherence corticosteroids calcipotriol focus groups Dermatology RL1-803 |
| spellingShingle |
Psoriasis adherence corticosteroids calcipotriol focus groups Dermatology RL1-803 Svendsen MT Andersen KE Andersen F Hansen J Pottegård A Johannessen H Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| description |
Mathias Tiedemann Svendsen,1–3 Klaus Ejner Andersen,1–3 Flemming Andersen,1,3 Jakob Hansen,4 Anton Pottegård,5 Helle Johannessen6 1Department of Dermatology and Allergy Centre, Odense University Hospital, 2Centre for Innovative Medical Technology, Institute of Clinical Research, University of Southern Denmark, Odense C, 3Dermatological Investigations Scandinavia, University of Southern Denmark, Odense C, 4Leo Pharma, Ballerup, 5Clinical Pharmacology, Department of Public Health, University of Southern Denmark, 6Research Unit of User Perspectives, Department of Public Health, University of Southern Denmark, Odense C, Denmark Abstract: Nonadherence to topical treatment of psoriasis is a common cause of treatment failure. This focus group study was conducted to obtain the patients’ own experiences and explanations regarding medical adherence. The participants consisted of eight primary adherent patients with moderate psoriasis treated with corticosteroid or corticosteroid–calcipotriol combinations, purposefully sampled by age and sex at a dermatology outpatient clinic. Secondary medical adherence was supported by accessibility of the prescribing physician, the prescriber taking time to listen, having a more manageable disease, using a nonstaining product, and establishing routines around treatment at home. Secondary medical adherence was affected negatively by changes in daily routines, if the treatment influenced the patient’s sexual life, having too little time in the consultation room, lack of confidence in the prescriber, diverging information from health care personnel, experiencing side effects, having fear of side effects, impractical formulations of topical products, and impatience regarding time before an effect of the treatment was observed. From this study, the recommendations for the prescribing doctor to improve medical adherence are, the doctor needs to take time to listen to the patient, prescribe a topical product that is easy to apply and less greasy, inform the patients about benefits from treatments, and explain the rationale behind the treatment plan. Keywords: psoriasis, adherence, corticosteroids, calcipotriol, focus groups |
| format |
article |
| author |
Svendsen MT Andersen KE Andersen F Hansen J Pottegård A Johannessen H |
| author_facet |
Svendsen MT Andersen KE Andersen F Hansen J Pottegård A Johannessen H |
| author_sort |
Svendsen MT |
| title |
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| title_short |
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| title_full |
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| title_fullStr |
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| title_full_unstemmed |
Psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| title_sort |
psoriasis patients’ experiences concerning medical adherence to treatment with topical corticosteroids |
| publisher |
Dove Medical Press |
| publishDate |
2016 |
| url |
https://doaj.org/article/c2070627e5e745959d5602a2042f0117 |
| work_keys_str_mv |
AT svendsenmt psoriasispatientsrsquoexperiencesconcerningmedicaladherencetotreatmentwithtopicalcorticosteroids AT andersenke psoriasispatientsrsquoexperiencesconcerningmedicaladherencetotreatmentwithtopicalcorticosteroids AT andersenf psoriasispatientsrsquoexperiencesconcerningmedicaladherencetotreatmentwithtopicalcorticosteroids AT hansenj psoriasispatientsrsquoexperiencesconcerningmedicaladherencetotreatmentwithtopicalcorticosteroids AT pottegaringrda psoriasispatientsrsquoexperiencesconcerningmedicaladherencetotreatmentwithtopicalcorticosteroids AT johannessenh psoriasispatientsrsquoexperiencesconcerningmedicaladherencetotreatmentwithtopicalcorticosteroids |
| _version_ |
1718398146854256640 |